What is Vivos Therapeutics, Inc.'s market cap?

Vivos Therapeutics, Inc. (VVOS) has a market capitalization of $5.6M and trades on NASDAQ.

Who are Vivos Therapeutics, Inc.'s competitors?

Vivos Therapeutics, Inc.'s key competitors include ResMed Inc., Philips Respironics, Inspire Medical Systems, Inc., and others. These companies compete in similar markets and product categories.

Who does Vivos Therapeutics, Inc. partner with?

Vivos Therapeutics, Inc.'s notable partners include MyCardio LLC, Rebis Health, Noum, Inc., and others.

What subsidiaries does Vivos Therapeutics, Inc. have?

Vivos Therapeutics, Inc.'s subsidiaries include BioModeling Solutions, Inc., First Vivos, Inc., Airway Integrated Management Company, LLC, and others.

Where is Vivos Therapeutics, Inc. headquartered?

Vivos Therapeutics, Inc. is headquartered in United States of America and employs approximately 114 people. It has been publicly traded since 2020.

Vivos Therapeutics, Inc.

VVOS

Vivos Therapeutics is a medical technology company that provides non-surgical, proprietary oral appliance therapies for treating obstructive sleep apnea (OSA) and snoring.

Market cap

$5.6M-79.0%

Table of contents

Earnings

Q1 2026 report

May 20, 2026

Revenue$5.1MBeat by $792.3K EPS-$0.52Miss by $0.07

Read the full report

Next report

Aug 18, 2026 (In 2 weeks)

Revenue estimate$5.6M

EPS estimate-$0.42

Competitors

By market cap

ResMed$29.5B-26.5%

Philips$24.3B+2.4%

Align Technology$12.0B-19.9%

Envista Holdings Corporation$4.3B+23.3%

AdaptHealth$1.5B+15.2%

Inspire Medical Systems$1.5B-61.9%

Viemed Healthcare, Inc.$464.6M+88.7%

Vivos Therapeutics, Inc.$5.6M-79.9%

By revenue growth

Viemed Healthcare, Inc.+23.1%

Envista Holdings Corporation+12.2%

ResMed+10.3%

Inspire Medical Systems+8.9%

Align Technology+2.9%

AdaptHealth+1.2%

By net margin

ResMed27.44%+1.3pp

Inspire Medical Systems14.33%+6.4pp

Align Technology10.5%+0.2pp

Viemed Healthcare, Inc.5.2%-0.1pp

Envista Holdings Corporation2.41%+47.4pp

AdaptHealth-2.42%-5.0pp

Profile

Vivos Therapeutics is a medical technology company that provides non-surgical, proprietary oral appliance therapies for treating obstructive sleep apnea (OSA) and snoring. The company utilizes its patented Vivos Method to remodel the upper airway in both adults and children, offering a limited-duration treatment alternative to lifetime CPAP or invasive surgery. Vivos is transitioning toward a vertically integrated model that combines medical device sales with healthcare services through managed sleep centers and dental/medical service organizations.

Competitive position

Vivos holds a unique market position as the provider of the only FDA-cleared oral appliance for severe OSA and pediatric OSA, competing primarily against traditional CPAP therapy and surgical interventions.

GeographiesUnited States, Canada, Middle East, North Africa

Customer segmentsHealthcare Providers, Medical Practices, Dental Practices

Business modelManufacturing, Management Services (MSO/DSO), Subscription, Direct-to-Provider

SuppliersThird-party laboratory manufacturers, Raw material suppliers (BPA-free polymers), Logistics and freight forwarders, Software developers

CustomersIndependent dental practices, Accredited sleep centers, Primary care physicians, Medicare and commercial insurance payers

CountryUnited States of America

Listed2020

Employees114.0

CEOR. Kirk Huntsman

SectorHealthcare

IndustryMedical - Devices

Websitevivos.com

FilingsSEC EDGAR

Questions, answered.

What is Vivos Therapeutics, Inc.'s market cap?: Vivos Therapeutics, Inc. (VVOS) has a market capitalization of $5.6M and trades on NASDAQ.
Who are Vivos Therapeutics, Inc.'s competitors?: Vivos Therapeutics, Inc.'s key competitors include ResMed Inc., Philips Respironics, Inspire Medical Systems, Inc., and others. These companies compete in similar markets and product categories.
Who does Vivos Therapeutics, Inc. partner with?: Vivos Therapeutics, Inc.'s notable partners include MyCardio LLC, Rebis Health, Noum, Inc., and others.
What subsidiaries does Vivos Therapeutics, Inc. have?: Vivos Therapeutics, Inc.'s subsidiaries include BioModeling Solutions, Inc., First Vivos, Inc., Airway Integrated Management Company, LLC, and others.
Where is Vivos Therapeutics, Inc. headquartered?: Vivos Therapeutics, Inc. is headquartered in United States of America and employs approximately 114 people. It has been publicly traded since 2020.